• Aurora Cannabis moved to challenge Curaleaf’s hostile bid disclosures, citing gaps it says limit investors’ ability to assess the offer.
• The filing targets missing pro forma financial information, which Aurora says is needed to evaluate the combined company’s financial profile.
• Aurora also disputes the bid timeline and related disclosure, warning its shareholder rights plan could be triggered above a 20% stake.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202609231827CANADANWCANADAPR_C3972) on September 23, 2026, and is solely responsible for the information contained therein.